Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema - Wikidata - awgldk - TriplyDB

Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema

Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema

http://www.wikidata.org/entity/Q28291061

about

Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema.Pigment epithelium-derived factor protects retinal ganglion cells.Emerging drugs for diabetic retinopathy.Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.PEDF regulates vascular permeability by a γ-secretase-mediated pathway.Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment.Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy Identification of a novel inhibitor of the canonical Wnt pathway.Angiogenesis in diabetes and obesity Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous.Comparison of aqueous concentrations of angiogenic and inﬂammatory cytokines based on optical coherence tomography patterns of diabetic macular edema.Delayed corneal epithelial healing after intravitreal bevacizumab: a clinical and experimental study.Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization.Characterization of the human aqueous humour proteome: A comparison of the genders.Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema.Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications.Pigment epithelium-derived factor secreted from retinal pigment epithelium facilitates apoptotic cell death of iPSC.GLUT1 activity contributes to the impairment of PEDF secretion by the RPE.Current and future approaches in the prevention and treatment of diabetic retinopathy.Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown.Effect of intraocular surgery and ketamine on aqueous and serum cytokines.Intravitreal bevacizumab: an analysis of the evidence.The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy.Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.Vitrectomy for center-involved diabetic macular edema.Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy.PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration.Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients.Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema.

P2860

Q28070894-A8CBE7C3-B3BC-4D00-98B3-F6B078C7D47D Q30874452-4D98456D-FE6F-4C31-BFDE-69D1B0CDE071 Q33270756-71059D47-7CDD-452B-B4F6-05E60A46D82B Q33388498-8264D30D-B4F6-420B-9DEA-9FF0D31B8422 Q33511170-339CA123-AA58-4113-9761-30CE2F4CE043 Q33542959-A74E9420-BC22-48F5-B99F-DA2E78FD6526 Q33642146-2FDD1E26-1BE7-4D61-AE36-6CCA08AE6ACE Q33806214-7E12BD31-8EBB-4E52-B9F6-C5E4C8F06808 Q33808055-9C1DA4AC-F528-47AC-85E6-657E126B8282 Q33938310-D3E5ED8B-3908-4116-B333-A0215B9FF785 Q33939170-D2FBEE19-2065-439B-899B-AEED7502A49B Q34217808-5E846194-6F40-48B3-AC9E-A8E218B331C3 Q34356152-E99A5980-6B72-43A7-B474-4E17727E100C Q35096644-75E45D35-C625-47BC-B4F7-E8B70F66A37C Q35153884-67130CE9-1462-491D-BC17-2D2BB645AD33 Q35575062-BBFA1266-D3FD-4B22-9B65-43EBC0D2715F Q35722473-822EE03D-8C8C-4300-A893-0C923FAED476 Q35835470-9142F332-3A79-4154-B2E3-65F6B685A77B Q36000069-F1119893-0B62-41B2-B862-A50A8D86152B Q36300702-F13AD83B-7908-41A7-B614-3F62EF7732F4 Q36324073-3BA1AECE-ABED-4EE1-B088-7113F5F130FD Q37058905-7B4EAC59-53C5-44D6-AB24-0635FA6DCCB4 Q37061346-ECDA56A7-68A8-44B6-B83F-C0ED4C8BBA19 Q37092364-4E6FDC1A-989D-404B-8E38-489EE0E5998E Q37221516-704B6BD6-94A6-4A63-95F5-8FB1C5516968 Q37283355-17C183DF-C783-44C4-BCC0-9C409B24751D Q37371699-2D3B73FB-56FA-48DF-B673-B5F238CAC167 Q37425415-4FCEE8B7-709D-4051-B888-42F85587A0EA Q37577410-7FAEAED1-83D8-43A8-891A-6FD76244C74A Q37820210-F0A16C09-E40A-4C35-88EB-9813BC3ACA73 Q38153731-7DC65C2D-C978-4940-8780-96F36765017B Q38572150-B48B3A92-68A2-4B09-8316-E146577CC84B Q40918766-6A9F6D84-7D21-44DC-A27A-06AAAF68D242 Q41122957-6729FBEA-5953-48F9-BABF-4CA297EE6E50 Q41370150-CE8F832C-4BDF-4A7E-B159-FD280606F5E9 Q41891788-8AEAF566-499F-4A8F-9E9C-732FB7C5ADB0 Q42057023-6E8E2C52-D469-49E2-8010-5F3C2B4C44BE Q42553869-6B70A089-BF5B-4862-8FFF-9653ED7DCDE0 Q43104088-ECBA0874-437C-4988-9290-B799B6C0EE58 Q43148680-9B656A46-66B8-4667-9FCB-89FB7E647345

P2860

Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema

http://www.wikidata.org/entity/Q28291061

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@ast

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@en

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@nl

type

label

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@ast

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@en

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@nl

prefLabel

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@ast

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@en

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@nl

P1433

Q28291061-7FAA7872-1C0B-4C55-BA3A-627F08ABFFCE

P1476

Q28291061-FAF07935-981A-4BF3-816A-8B15708DCF0B

P2093

Q28291061-39962F8D-02FD-4235-BF33-33F9EFEF07B9

Q28291061-3EF0B236-106B-4666-A6AF-C792DE471E77

Q28291061-457C9F18-53E4-4BC6-B68C-A52E74EB3EB7

Q28291061-4EEBA98E-27A9-40FE-98BE-B4277C3A198F

Q28291061-84AD2E40-E83D-4A92-8D96-B79407044724

Q28291061-DD8266C1-5361-4152-949C-D3F6C70FEA26

Q28291061-F228A9B1-7C99-4E0D-BFD6-7A440DE80ADC

P304

Q28291061-791F0EB7-E538-4B0D-9A28-EB8BBF442A6E

P31

Q28291061-E374FE34-F8D9-4C98-BE98-71E95E37FC5A

P3181

Q28291061-62661E41-D71F-4745-AD88-B80DBC0EEE53

P356

Q28291061-FA6F3079-F568-42D3-BB60-10A5A81744E3

P407

Q28291061-93DA0EAE-6728-436E-B6A3-AD2FE485E781

P433

Q28291061-FB1BA919-A62B-4D97-A9C9-03C61B4CCB17

P478

Q28291061-006F33FB-1E2E-417B-BCE6-69BDE0B0F059

P577

Q28291061-4FB3E282-A9D1-4AD7-AA87-783E09DA2FE0

P698

Q28291061-C83C81F6-765B-4D0C-AD68-0CE73AB543FD

P921

Q28291061-9978AA73-B4E0-45A6-90A8-442D4E8C90EE

P3181

P356

J.OPHTHA.2005.10.030

P1433

P1476

Vitreous levels of pigment epi ...... ated to diabetic macular edema

@en

P2093

Hideharu Funatsu

http://www.w3.org/2001/XMLSchema#string

Hidetaka Noma

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Yamashita

http://www.w3.org/2001/XMLSchema#string

Sadao Hori

http://www.w3.org/2001/XMLSchema#string

Shinko Nakamura

http://www.w3.org/2001/XMLSchema#string

Shuichiro Eguchi

http://www.w3.org/2001/XMLSchema#string

Tatsuya Mimura

http://www.w3.org/2001/XMLSchema#string

P304

294-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2076119

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.OPHTHA.2005.10.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16406543

http://www.w3.org/2001/XMLSchema#string

P921